The Cell Therapy section of Frontiers in Molecular Medicine publishes basic, translational and clinical studies across the field of gene and cell therapy for the diagnosis and treatment of human diseases.
The purpose of this specialty section is to cover all the aspects of cell therapy with explicit implication in ameliorating human health.
Areas covered by this section include, but are not limited to:
• Molecular mechanisms regulating cell function • Tools for diagnosis • Innovative treatments • New Technologies
• Molecular mechanisms regulating cell function
• Tools for diagnosis
• Innovative treatments
• New TechnologiesThe Cell Therapy section of Frontiers in Molecular Medicine is devoted to providing new diagnostic and therapeutic tools through cell therapy by integrating interdisciplinary knowledge from cell biology, molecular biology, genetics and drug development. This Specialty Section hosts articles dealing with stem cell and regenerative therapies to treat genetic and acquired diseases. Articles exploring other aspects of molecular medicine including microbes and disease, bioinformatics and artificial intelligence and virotherapy could be a better fit for the journal sections in Molecular Microbes and Disease, Bioinformatics & Artificial Intelligence for Molecular Medicine and Gene & Virotherapy. The section welcomes the following article types: Original Research, Review, Mini-Review, Methods, Perspective, Opinion, Editorial, General Commentary, Data Report, Hypothesis and Theory. The quality standards for experimental studies are listed below: The statistical significance of quantitative analysis must be secured by a minimum of three biological replicates. This is applied to all the studies involving quantitative assays including transcriptomics, proteomics, metabolomics, phenotypic measurements, and qPCR expression analysis. Studies that do not comply with these replication requirements will not be considered eligible for review. A declaration regarding studies using animals should comply with the ARRIVE guidelines (Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG (2010).
Indexed in: Google Scholar, CrossRef, CLOCKSS, OpenAIRE
Cell Therapy welcomes submissions of the following article types: Brief Research Report, Correction, Data Report, Editorial, General Commentary, Hypothesis and Theory, Methods, Mini Review, Opinion, Original Research, Perspective, Review, Specialty Grand Challenge and Technology and Code.
All manuscripts must be submitted directly to the section Cell Therapy, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact firstname.lastname@example.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact email@example.com